Drug profile · INN
caffeine citrate
BLECTIFOR
caffeine citrate (BLECTIFOR) is a adenosine receptor antagonist. Associated with Viridian Pharma Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — caffeine citrate
- US status
- approved
- Class
- Nervous system (N06)
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
caffeine citrate (BLECTIFOR) is a adenosine receptor antagonist. Associated with Viridian Pharma Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adenosine receptor antagonist
Primary target: Adenosine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is caffeine citrate?
caffeine citrate (BLECTIFOR) is a adenosine receptor antagonist. Associated with Viridian Pharma Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for caffeine citrate?
BLECTIFOR is a marketed brand name for caffeine citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of caffeine citrate?
caffeine citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.